Cybersecurity

IsoPSA Prostate Cancer Test – Review
Regulatory & Compliance IsoPSA Prostate Cancer Test – Review

For decades, the uncertainty surrounding an elevated Prostate-Specific Antigen (PSA) test has placed countless men and their physicians in a difficult position, often leading to invasive procedures that prove unnecessary. The IsoPSA blood test represents a significant advancement in prostate cancer

Five Healthcare Security Myths Endanger Patients
Regulatory & Compliance Five Healthcare Security Myths Endanger Patients

In an industry where patient trust is paramount, the digital vulnerabilities lurking within healthcare systems pose a threat that extends far beyond lost data, directly impacting patient safety and well-being. Many healthcare organizations, from bustling urban hospitals to quiet suburban clinics,

New Bill Aims to Fortify Healthcare Cybersecurity
Regulatory & Compliance New Bill Aims to Fortify Healthcare Cybersecurity

In the wake of an unprecedented wave of digital assaults that left the sensitive data of over 190 million Americans exposed in 2024 alone, a bipartisan group of senators has introduced landmark legislation designed to fundamentally reshape the nation's healthcare cybersecurity defenses. The

Sturgis Hospital Breach: Are Your SSN and Health Data Safe?
Regulatory & Compliance Sturgis Hospital Breach: Are Your SSN and Health Data Safe?

Imagine receiving a letter from a hospital informing you that your Social Security number, health records, and financial details have been exposed to an unknown third party due to a cyberattack, a terrifying reality now faced by over 77,000 individuals connected to Sturgis Hospital in Michigan.

Are Biotech Firms Failing to Protect Sensitive Genomic Data?
Regulatory & Compliance Are Biotech Firms Failing to Protect Sensitive Genomic Data?

In an era where personalized medicine holds the promise of revolutionizing healthcare, the security of sensitive genomic data has emerged as a critical concern for the biotech industry, with recent findings from a comprehensive security posture report revealing startling vulnerabilities in the

J&J Recalls Impella Heart Pump Over Cybersecurity Risks
Regulatory & Compliance J&J Recalls Impella Heart Pump Over Cybersecurity Risks

In an era where medical technology saves countless lives, a startling vulnerability has emerged in one of the most critical devices used in cardiac care, raising serious concerns about patient safety. Johnson & Johnson’s Abiomed unit has initiated a Class I recall of its Impella heart pump

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later